Marriott Harrison LLP advises on AIM IPO of Polarean Imaging Plc

Friday 6th April, 2018

Corporate partner Simon Charles, Corporate associate Marina Ehrlich and Life Sciences partner Julian Hitchcock advised Northland Capital Partners Limited in its capacity as nominated adviser and broker to Polarean Imaging Plc, a medical imaging technology company which has developed technology that can spot the early signs of chronic obstructive pulmonary disease by using a radiation-free gas to enhance MRI scans and provide a clearer image of patients’ lungs. Polarean Imaging Plc raised £3 million against a market capitalisation of £11 million and admitted to AIM on 29 March 2018.